New Genetic Variant Linked to Anxiety
Author Information
Author(s): Kristin R. Anderson, Wenpeng Cao, Hui Sun Lee, Mark A. Crenshaw, Talulla B. Palumbo, Ethan Fisher-Perez, Amanda DeGraaf, Peter Rogu, Maria A. Beatty, Gabrielle M. Gracias, Avani V. Pisapati, Katie Hoffman, Krystle J. McLaughlin, Almut Hupbach, Im Wonpil, X. Frank Zhang, Julie M. Miwa
Primary Institution: Lehigh University
Hypothesis
Does the LYNX2 gene variant affect anxiety levels in humans?
Conclusion
The LYNX2 Q39H variant is associated with increased anxiety levels comparable to those seen in diagnosed anxiety disorders.
Supporting Evidence
- A specific LYNX2 SNP is linked to a reduced binding affinity between the LYNX2 protein and nicotinic acetylcholine receptors.
- Individuals with the Q39H mutation reported anxiety levels similar to those diagnosed with anxiety disorders.
- The study identified a novel SNP in the LYNX2 gene that had not been previously reported.
Takeaway
Some people have a gene change that makes them feel more anxious, like when you're scared of the dark. This study found that this change can make them feel anxious even if they don't have a doctor's label for it.
Methodology
Participants completed anxiety questionnaires and DNA analysis was performed to identify SNPs in the LYNX2 gene.
Potential Biases
The study relied on self-reported anxiety measures, which can be subjective.
Limitations
The study's population was primarily young adults, which may not represent older individuals with anxiety disorders.
Participant Demographics
The cohort consisted of 624 participants, with an average age of 20.7 years, including 179 males and 416 females.
Statistical Information
P-Value
p<1.0 × 10–4
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website